Trial Profile
A prospective observational study on the efficacy of switching to sertraline in depressive patients who failed treatment with duloxetine
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Major depressive disorder
- Focus Pharmacogenomic; Therapeutic Use
- 19 Jan 2013 Primary endpoint added as reported by University Hospital Medical Information Network - Japan record.
- 18 Jan 2013 New trial record